GE HealthCare Technologies (GEHC) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of GE HealthCare Technologies (NASDAQ: GEHC) recently:

• 11/3/2026 – GE HealthCare Technologies had its price target raised by UBS Group from $73.00 to $80.00. They now have a “neutral” rating on the stock.
• 10/31/2026 – GE HealthCare Technologies was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/29/2026 – GE HealthCare Technologies had its price target raised by Citigroup from $71.00 to $79.00. They now have a “neutral” rating on the stock.
• 10/29/2026 – GE HealthCare Technologies had its price target raised by Barclays from $85.00 to $95.00. They now have an “overweight” rating on the stock.
• 10/29/2026 – GE HealthCare Technologies had its “neutral” rating reaffirmed by Bank of America.
• 10/29/2026 – GE HealthCare Technologies had its price target raised by JPMorgan Chase & Co. from $70.00 to $80.00. They now have a “neutral” rating on the stock.
• 10/29/2026 – GE HealthCare Technologies had its price target raised by Royal Bank Of Canada from $80.00 to $90.00. They now have an “outperform” rating on the stock.
• 10/28/2026 – GE HealthCare Technologies had its price target raised by BTIG Research from $75.00 to $83.00. They now have a “buy” rating on the stock.
• 10/20/2026 – GE HealthCare Technologies is now covered by Wolfe Research. They set a “peer perform” rating on the stock.
• 10/12/2026 – GE HealthCare Technologies had its price target lowered by BTIG Research from $79.00 to $75.00. They now have a “buy” rating on the stock.
• 10/7/2026 – GE HealthCare Technologies was upgraded by Barclays to “strong-buy”.
• 10/6/2026 – GE HealthCare Technologies is now covered by Barclays. They set an “overweight” rating and a $85.00 price target on the stock.
• 10/6/2026 – GE HealthCare Technologies was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 10/5/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $93.00 price target on the stock.
• 10/5/2026 – GE HealthCare Technologies had its “outperform” rating reaffirmed by Royal Bank Of Canada.
• 10/5/2026 – GE HealthCare Technologies had its price target lowered by Citigroup from $75.00 to $71.00. They now have a “neutral” rating on the stock.
• 9/22/2026 – GE HealthCare Technologies is now covered by Needham & Company LLC. They set a “buy” rating and a $93.00 price target on the stock.
• 9/22/2026 – GE HealthCare Technologies is now covered by Needham & Company LLC. They set a “buy” rating and a $93.00 price target on the stock.
• 9/17/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by BTIG Research. They now have a $79.00 price target on the stock.

GE HealthCare Technologies Trading Up 2.0%

Shares of GE HealthCare Technologies stock traded up $1.65 on Monday, hitting $84.03. 4,238,810 shares of the company’s stock traded hands, compared to its average volume of 4,283,585. The company has a fifty day moving average of $69.32 and a two-hundred day moving average of $70.05. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a market capitalization of $37.99 billion, a price-to-earnings ratio of 17.73, a price-to-earnings-growth ratio of 2.07 and a beta of 0.65. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. The business had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.07 earnings per share. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a dividend of $0.04 per share. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.38%.

GE HealthCare Technologies Inc is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings.

The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

GE HealthCare became an independent publicly traded company in January 2023 through its separation from General Electric.